THEO-24 Drug Patent Profile
✉ Email this page to a colleague
When do Theo-24 patents expire, and when can generic versions of Theo-24 launch?
Theo-24 is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in THEO-24 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theo-24
A generic version of THEO-24 was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THEO-24?
- What are the global sales for THEO-24?
- What is Average Wholesale Price for THEO-24?
Summary for THEO-24
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Patent Applications: | 3,955 |
| DailyMed Link: | THEO-24 at DailyMed |
Pharmacology for THEO-24
| Drug Class | Methylxanthine |
US Patents and Regulatory Information for THEO-24
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | THEO-24 | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 087943-002 | Aug 22, 1983 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | THEO-24 | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 087943-004 | Feb 28, 1992 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | THEO-24 | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 087943-001 | Aug 22, 1983 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | THEO-24 | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 087943-003 | Aug 22, 1983 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
